glp-1 eye issues Drugs and Ocular Disease: Between Neuroprotection and Risk GLP-1 Drugs and Diabetic Eye
Description
Clinical Significance: The 2025 updates reaffirm that while HbA1c remains central, a one-number-fits-all strategy is outdated
Aids sustainable weight management
Eli Lilly (NYSE:LLY) plans to invest over US$3.5b in a new Pennsylvania manufacturing facility focused on next generation injectable weight loss therapies
Schedule today.
